Inpharma Weekly

, Volume 1425, Issue 1, pp 5–5 | Cite as

Carboplatin affords superior QOL versus cisplatin in NSCLC

Clinical study
  • 6 Downloads

Keywords

Carboplatin Mitomycin Vinblastine Tumour Response Rate Entire Treatment Period 

Copyright information

© Adis International Ltd 2004

Personalised recommendations